The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
Kumar, Divya P., Caffrey, Rebecca, Marioneaux, Jonathon, Santhekadur, Prasanna K., Bhat, Madhavi, Alonso, Cristina, Koduru, Srinivas V., Philip, Binu, Jain, Mukul R., Giri, Suresh R., Bedossa, Pierre,Том:
10
Журнал:
Scientific Reports
DOI:
10.1038/s41598-020-66458-z
Date:
December, 2020
Файл:
PDF, 2.48 MB
2020
File converter
Більше результатів пошуку
More benefits 
